NEW YORK (GenomeWeb) – Belgian biopharmaceutical developer UCB announced today that it has acquired Durham, North Carolina-based Element Genomics for $30 million, which will include upfront and short-term success-based milestone payments.

A biotech spinout from Duke University, Element Genomics has developed several technologies to further understand genome structure and functions, such as CRISPR editing technology for genomic and epigenetic regulatory region analysis and modulation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.